205 related articles for article (PubMed ID: 33376061)
1. Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation.
D'Onofrio M; Tedesco G; Cardobi N; De Robertis R; Sarno A; Capelli P; Martini PT; Giannotti G; Beleù A; Marchegiani G; Gobbo S; Butturini G; Bogdan M; Salvia R; Bassi C
Pancreatology; 2021 Jan; 21(1):180-187. PubMed ID: 33376061
[TBL] [Abstract][Full Text] [Related]
2. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
[TBL] [Abstract][Full Text] [Related]
3. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
Do RK; Katz SS; Gollub MJ; Li J; LaFemina J; Zabor EC; Moskowitz CS; Klimstra DS; Allen PJ
AJR Am J Roentgenol; 2014 Nov; 203(5):973-9. PubMed ID: 25341134
[TBL] [Abstract][Full Text] [Related]
4. Computed high-b-value high-resolution DWI improves solid lesion detection in IPMN of the pancreas.
Harder FN; Jung E; Weiss K; Graf MM; Kamal O; McTavish S; Van AT; Demir IE; Friess H; Phillip V; Schmid RM; Lohöfer FK; Kaissis GA; Makowski MR; Karampinos DC; Braren RF
Eur Radiol; 2023 Oct; 33(10):6892-6901. PubMed ID: 37133518
[TBL] [Abstract][Full Text] [Related]
5. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of magnetic resonance image for malignant intraductal papillary mucinous neoplasms: the importance of size of enhancing mural nodule within cyst.
Hong SB; Lee NK; Kim S; Seo HI; Park YM; Noh BG; Kim DU; Han SY; Kim TU
Jpn J Radiol; 2022 Dec; 40(12):1282-1289. PubMed ID: 35781178
[TBL] [Abstract][Full Text] [Related]
7. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
[TBL] [Abstract][Full Text] [Related]
8. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas using MR findings and texture analysis.
Jeon SK; Kim JH; Yoo J; Kim JE; Park SJ; Han JK
Eur Radiol; 2021 May; 31(5):3394-3404. PubMed ID: 33140171
[TBL] [Abstract][Full Text] [Related]
9. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up.
Uehara H; Ishikawa O; Katayama K; Kawada N; Ikezawa K; Fukutake N; Takakura R; Takano Y; Tanaka S; Takenaka A
J Gastroenterol; 2011 May; 46(5):657-63. PubMed ID: 21085997
[TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
Min JH; Kim YK; Kim SK; Kim H; Ahn S
Eur Radiol; 2021 Jul; 31(7):4774-4784. PubMed ID: 33409798
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm.
Ogawa T; Horaguchi J; Fujita N; Noda Y; Kobayashi G; Ito K; Koshita S; Kanno Y; Masu K; Sugita R
J Hepatobiliary Pancreat Sci; 2014 Nov; 21(11):801-8. PubMed ID: 25082473
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
14. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
[TBL] [Abstract][Full Text] [Related]
15. Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging.
Zhang H; Cao Y; Ren S; Guo K; Zhang Y; Lin T; Wang Y; Chen X; Wang Z
Technol Cancer Res Treat; 2023; 22():15330338231170942. PubMed ID: 37078135
[No Abstract] [Full Text] [Related]
16. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
17. Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines.
Lee JE; Choi SY; Min JH; Yi BH; Lee MH; Kim SS; Hwang JA; Kim JH
Radiology; 2019 Oct; 293(1):134-143. PubMed ID: 31478800
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm.
Kawakami S; Fukasawa M; Shimizu T; Ichikawa S; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Hayakawa H; Nakayama Y; Yamaguchi T; Inoue T; Maekawa S; Kawaida H; Motosugi U; Onishi H; Enomoto N
Medicine (Baltimore); 2019 Nov; 98(47):e18039. PubMed ID: 31764824
[TBL] [Abstract][Full Text] [Related]
19. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
20. Value of 3-T MR imaging in intraductal papillary mucinous neoplasm with a concomitant invasive carcinoma.
Sotozono H; Kanki A; Yasokawa K; Yamamoto A; Sanai H; Moriya K; Tamada T
Eur Radiol; 2022 Dec; 32(12):8276-8284. PubMed ID: 35665843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
